Novel insights into myocardial fibrosis in patients with new onset ST-elevation myocardial infarction following percutaneous coronary intervention through enhanced cardiac magnetic resonance imaging: a prospective cohort study

Table 3 Univariable and multivariable linear regression analyses for the prediction of myocardial fibrosis

Variable	Univariable Model		Multivariable Model
Variable	β	p value	β	p value
Current smoker, n(%)	0.017	0.880
TN-I (µg/L)	0.349	0.002
LDL-C (mmol/L)	0.094	0.416
CK-MB (U/L)	0.082	0.488
Symptom onset to reperfusion (h)	-0.039	0.742
NT-proBNP	2.444	0.017
Gensini score	0.456	0.000	0.258	0.004
LVEDV (mL)	0.300	0.008
LVESV (mL)	0.496	0.001
LVEF (%)	-0.598	0.001	-0.269	0.022
Myocardial mass	0.379	0.001
MVO	0.523	0.000	0.343	0.000
WMA	0.336	0.003
GRS	-0.434	0.000
GCS	-0.547	0.000	-0.227	0.037
GLS	-0.437	0.001
IRS	-0.380	0.000
ICS	-0.517	0.001
ILS	-0.424	0.000

Note: LDL-C: low-density lipoprotein cholesterol; CK-MB: creatinine kinase (MB); TN-I: troponin-I; NT-proBNP: N-terminal pro brain natriuretic peptide; LVEDV: left ventricular end-diastolic volume; LVESV: left ventricular end-systolic volume; LVEF: left ventricular ejection fraction; MVO: microvascular obstruction; WMA: wall motion abnormality; GRS: global radial strain; GCS: global circumferential strain; GLS: global longitudinal strain; IRS: infarcted segment radial strain; ICS: infarcted segment circumferential strain; ILS: infarcted segment longitudinal strain

ISSN: 1471-2261